tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB

Genmab (GMAB) Similar Stocks

Compare
741 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Genmab
$33.72
$20.63B
14.20
63.85%
5 Buy
2 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$60.16
$11.56B
22.54
-10.24%
14 Buy
5 Hold
0 Sell
Moderate Buy
Incyte
$100.44
$19.72B
16.85
44.39%
9 Buy
8 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$212.81
$13.00B
-50.11
51.67%
13 Buy
0 Hold
0 Sell
Strong Buy
BioNTech SE
$95.03
$22.85B
-36.12
-16.47%
12 Buy
3 Hold
0 Sell
Strong Buy
Royalty Pharma
$39.39
$22.66B
22.44
58.39%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GMAB
Genmab
33.72
12.70
60.42%
BMRN
BioMarin Pharmaceutical
60.16
-6.73
-10.06%
INCY
Incyte
100.44
31.21
45.08%
ASND
Ascendis Pharma
212.81
75.31
54.77%
BNTX
BioNTech SE
95.03
-18.92
-16.60%
RPRX
Royalty Pharma
39.25
14.34
57.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts